Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
NEW YORK, June 20, 2017 -- Luxury mattress manufacturer Unicorn Sleep says there is hope for patients with stage IV breast cancer.
“We believe in the power of research,” explained Unicorn Sleep CEO Chris Syed. “When properly funded, more life-extending treatments and therapies for stage IV breast cancer will be found.”
To help fund that research, Unicorn Sleep recently introduced a METAvivor mattress. The company donates 30 percent of profits from those sales to the charity METAvivor. METAvivor is a patient-led, non-profit organization that funds research, raises awareness, advocates for, and provides support to people with stage IV (metastatic) breast cancer.
“We at METAvivor are thrilled to partner with Unicorn Sleep. The generosity, care and concern of this company is humbling. Unicorn Sleep understands that research will make a difference for stage IV metastatic breast cancer. And for those patients who have bone metastasis it is really important to have a high quality mattress!” said METAvivor President Beth Fairchild.
Stage IV metastatic breast cancer (MBC) is defined by the spread of breast cancer to non-adjacent organs and is fatal in 97–99 percent of cases. In the U.S., more than 40,000 people die from MBC every year.
METAvivor awards grants for research projects that have the potential to shift MBC from a terminal disease to a chronic condition with a good quality of life. 100 percent of every donation given to METAvivor goes toward funding these grants.
“Unicorn Sleep was founded with the belief that good sleep is a vital part of good health and that giving back to the community is a responsibility we all share,” Syed explained. “The METAvivor mattress helps us achieve both.”
Unlike many direct-to-consumer mattress companies, Unicorn Sleep offers a choice of firmness. The handcrafted, 10-comfort-layer mattresses are built with the finest natural, high-quality components and include free white glove delivery and setup, removal, and a 150-night trial period—one of the longest in the industry.
About Unicorn Sleep
Unicorn Sleep produces all-natural, high-quality bedding products. Mattresses are delivered directly to the consumer via white glove delivery service and come with an industry-leading 150-night trial period. For more information, visit www.UnicornSleep.com.
Media Contact Jennifer Butsch Petit WordUp Public Relations [email protected] 757-656-9673
